Mounjaro, DailyMed (2026) FDA approves new medication for chronic weight management, US Food and Drug Administration (2023) Mounjaro, PDR Tirzepatide, StatPearls (2024) Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022-2025), Healthcare (Basel, Switzerland) (2025) Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity, Sleep Medicine (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Giving up means losing whatever progress you have made
Zepbound contains semaglutide, which activates only GLP-1 receptors
Each type needs a different treatment
The primary outcome consists of histological improvement of NASH (2 points of NASH activity score)
Rather than simply hoping to stay active, the Centenarian Decathlon asks: What do you want to be able to do when youre 100